AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $7.233M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| MTL | Ann: Quarterly Activities Report | 23/04/18 | 0 | 48 | |||
|
|||||||
| MTL | Ann: Appendix 4C - quarterly | 23/04/18 | 0 | 51 | |||
|
|||||||
| MTL | Ann: Becoming a substantial holder | 20/04/18 | 0 | 86 | |||
|
|||||||
| MTL | Ann: Response to ASX Query Letter | 12/04/18 | 0 | 188 | |||
|
|||||||
| MTL | Ann: Becoming a substantial holder | 10:18 | 0 | 134 | |||
|
|||||||
| MTL | Ann: Change in substantial holding | 08:39 | 0 | 87 | |||
|
|||||||
| MTL | Ann: Prospectus | 22/03/18 | 0 | 136 | |||
|
|||||||
| MTL | Ann: Appendix 3B | 21/03/18 | 0 | 76 | |||
|
|||||||
See All Discussions
ASX News